Financials Stemtech Corporation

Equities

STEK

US85859W1027

Pharmaceuticals

Market Closed - OTC Markets 20:59:37 10/05/2024 BST 5-day change 1st Jan Change
0.058 USD -1.69% Intraday chart for Stemtech Corporation -1.69% +78.46%

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 105.9 4.621
Enterprise Value (EV) 1 106.5 5.774
P/E ratio -12.5 x -0.47 x
Yield - -
Capitalization / Revenue 24.5 x 1.01 x
EV / Revenue 24.7 x 1.27 x
EV / EBITDA -38.3 x -1.85 x
EV / FCF -1,787,516,134 x 7,228,089 x
FCF Yield -0% 0%
Price to Book -31.6 x -1.98 x
Nbr of stocks (in thousands) 44,686 51,342
Reference price 2 2.370 0.0900
Announcement Date 01/04/22 11/05/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales 1 6.618 4.385 4.321 4.559
EBITDA 1 -2.182 -1.002 -2.782 -3.118
EBIT 1 -2.635 -1.432 -3.21 -5.023
Operating Margin -39.82% -32.66% -74.29% -110.18%
Earnings before Tax (EBT) 1 -2.841 -1.728 -7.111 -8.537
Net income 1 -2.791 -0.9167 -7.077 -8.545
Net margin -42.18% -20.91% -163.78% -187.41%
EPS 2 -0.5200 -0.1000 -0.1900 -0.1900
Free Cash Flow - 0.582 -0.0596 0.7988
FCF margin - 13.27% -1.38% 17.52%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 20/08/21 20/08/21 01/04/22 11/05/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 0.59 0.76 0.62 1.15
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) -0.2689 x -0.7544 x -0.2236 x -0.3697 x
Free Cash Flow - 0.58 -0.06 0.8
ROE (net income / shareholders' equity) - -90.7% 520% 241%
ROA (Net income/ Total Assets) - -16.5% -37.4% -62.9%
Assets 1 - 5.557 18.92 13.59
Book Value Per Share 2 0.4400 0.1900 -0.0800 -0.0500
Cash Flow per Share 2 0.0500 0.0100 0.0200 0
Capex 1 0.05 0.01 - -
Capex / Sales 0.68% 0.26% - -
Announcement Date 20/08/21 20/08/21 01/04/22 11/05/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. STEK Stock
  4. Financials Stemtech Corporation